Innoviz director granted 110,668 RSUs in stock award
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
Innoviz Technologies Ltd. director Aharon Aharon received a compensation grant of 110,668 Restricted Share Units (RSUs) on May 13, 2026. Each RSU gives the right to one ordinary share with no exercise price, so there is no cash paid to acquire these shares.
The RSUs will fully vest on April 5, 2027, if he remains a service provider to the company on that date. After this grant, he directly holds 344,997 ordinary shares, including 234,329 ordinary shares already held before this award.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Ordinary Shares | 110,668 | $0.00 | $0.00 |
Footnotes (2)
- F1. Represents 110,668 Restricted Share Units (RSUs) granted on May 13, 2026, which shall fully vest on April 5, 2027, subject to the Reporting Person remaining a service provider of the Issuer on the vesting date. Each RSU represents a contingent right to receive one ordinary share. No exercise price is applicable.
- F2. Includes 234,329 ordinary shares.
Key Figures
Key Terms
vesting financial
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What did Innoviz (INVZ) director Aharon Aharon report in this Form 4?
How many Innoviz (INVZ) RSUs were granted and when do they vest?
Does the Innoviz (INVZ) RSU grant to Aharon Aharon require any purchase price?
Is this Innoviz (INVZ) Form 4 transaction a buy or sell in the market?
AI-generated analysis. How Rhea-AI works. Not financial advice.